FdaApplication
ANDA 203994
Identifiers
- fda_app_no: ANDA203994
Properties
| Property | Value |
|---|---|
| applicant_name | NORTHLAND NUCLEAR MEDICINE LLC |
| application_type | ANDA |
| approval_date | 2015-02-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | 4-500mCi/ML | INJECTABLE;INTRAVENOUS |
1 product